Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Antibody-Based Therapeutics	850.00K

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
United States	850.00K